MedTrace Logo

5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities

NCT03606122 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-08-28

No results posted yet for this study

Summary

This study evaluates the potential usefulness of photodynamic therapy with PD P 506 A in patients with actinic keratosis on the upper extremities for the first time.

Conditions

  • Actinic Keratoses

Interventions

DRUG

PD P 506 A

PD P 506 A is a dermal patch of 4 cm² in size loaded with 2 mg 5-ALA (as 5-ALA HCl) per cm²

Sponsors & Collaborators

  • photonamic GmbH & Co. KG

    lead INDUSTRY

Principal Investigators

  • Uwe Reinhold, Professor · Dermatologisches Zentrum Bonn

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-12
Primary Completion
2019-07-16
Completion
2019-07-16

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03606122 on ClinicalTrials.gov